Skip Header

 
Contribute Send feedback

Reviewed, UniProtKB/Swiss-Prot P49792 (RBP2_HUMAN)

Last modified November 25, 2008. Version 99. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (7) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Binary interactions · Sequence annotation (Features) · Sequences · References · Web resources · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    E3 SUMO-protein ligase RanBP2
Alternative name(s):
    Ran-binding protein 2
    Nuclear pore complex protein Nup358
    Nucleoporin Nup358
    358 kDa nucleoporin
    p270
Gene names
Name: RANBP2
Synonyms: NUP358
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length3224 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is not processed.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

E3 SUMO-protein ligase which facilitates SUMO1 and SUMO2 conjugation by UBE2I. Involved in transport factor (Ran-GTP, karyopherin)-mediated protein import via the F-G repeat-containing domain which acts as a docking site for substrates. Could also have isomerase or chaperone activity and may bind RNA or DNA. Component of the nuclear export pathway. Specific docking site for the nuclear export factor exportin-1.

Pathway

Protein modification; protein sumoylation.

Subunit structure

Forms a tight complex with RANBP1 and UBE2I. Interacts with SUMO1 but not SUMO2. Interacts with PARK2. Interacts with sumoylated RANGAP1.

Subcellular location

Nucleusnuclear pore complex. Note= Cytoplasmic filaments.

Domain

Contains F-X-F-G repeats.

Post-translational modification

Polyubiquitinated by PARK2, which leads to proteasomal degradation.

Sequence similarities

Contains 1 PPIase cyclophilin-type domain.

Contains 4 RanBD1 domains.

Contains 8 RanBP2-type zinc fingers.

Contains 1 TPR repeat.

Binary interactions

With

Entry

#Exp.

IntAct

Notes

PARK2O602606EBI-973138,EBI-716346
TOP2AP113881EBI-973138,EBI-539628
Top2aQ013201EBI-973138,EBI-642809From a different organism.
UBE2IP632791EBI-973138,EBI-80168

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 32243224E3 SUMO-protein ligase RanBP2
PRO_0000204913

Regions

Repeat60 – 9334TPR
Domain1171 – 1307137RanBD1 1
Domain2012 – 2148137RanBD1 2
Domain2309 – 2445137RanBD1 3
Repeat2633 – 2685531
Repeat2711 – 2761512
Domain2911 – 3046136RanBD1 4
Domain3067 – 3223157PPIase cyclophilin-type
Zinc finger1351 – 138131RanBP2-type 1
Zinc finger1415 – 144430RanBP2-type 2
Zinc finger1479 – 150830RanBP2-type 3
Zinc finger1543 – 157230RanBP2-type 4
Zinc finger1606 – 163530RanBP2-type 5
Zinc finger1665 – 169430RanBP2-type 6
Zinc finger1724 – 175330RanBP2-type 7
Zinc finger1781 – 181030RanBP2-type 8
Region2631 – 26355Interaction with sumoylated RANGAP1
Region2633 – 27611292 X 50 AA approximate repeats
Region2633 – 271078Required for E3 SUMO-ligase activity
Region2633 – 268553Interaction with UBE2I
Region2686 – 276176Interaction with SUMO1

Amino acid modifications

Modified residue191Phosphothreonine
Modified residue211Phosphoserine
Modified residue3941Phosphoserine
Modified residue7791Phosphothreonine
Modified residue7811Phosphoserine
Modified residue7881Phosphoserine
Modified residue7961Phosphoserine
Modified residue7991Phosphothreonine
Modified residue9481Phosphoserine
Modified residue9551Phosphoserine
Modified residue11101Phosphoserine
Modified residue11441Phosphothreonine
Modified residue11601Phosphoserine
Modified residue13961Phosphothreonine
Modified residue13991Phosphothreonine
Modified residue14001Phosphoserine
Modified residue14121Phosphothreonine
Modified residue14431Phosphoserine
Modified residue14471Phosphoserine
Modified residue14561Phosphoserine
Modified residue15091Phosphoserine
Modified residue15731Phosphoserine
Modified residue17311Phosphoserine
Modified residue18691Phosphoserine
Modified residue21281Phosphothreonine
Modified residue21531Phosphothreonine
Modified residue22461Phosphoserine By similarity
Modified residue22511Phosphoserine By similarity
Modified residue22701Phosphoserine
Modified residue22761Phosphoserine
Modified residue22801Phosphoserine
Modified residue22901Phosphoserine
Modified residue22931Phosphothreonine By similarity
Modified residue22971Phosphoserine By similarity
Modified residue24471Phosphoserine
Modified residue24501Phosphothreonine
Modified residue24541Phosphoserine
Modified residue25101Phosphoserine
Modified residue25181Phosphoserine
Modified residue26131Phosphothreonine
Modified residue26681Phosphoserine
Modified residue27411Phosphoserine
Modified residue27431Phosphothreonine
Modified residue28071Phosphoserine
Modified residue29001Phosphoserine
Modified residue32071Phosphoserine
Cross-link2592Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)

Natural variations

Natural variant5481V → L: dbSNP rs1057954.
VAR_029765
Natural variant5801E → K: dbSNP rs4012065.
VAR_029766
Natural variant5811C → Y: dbSNP rs1057957.
VAR_029767
Natural variant7841R → K: dbSNP rs2912838.
VAR_023939
Natural variant18701P → L: dbSNP rs2889846.
VAR_029768
Natural variant18921P → A: dbSNP rs12770.
VAR_014886

Experimental info

Mutagenesis26321V → K: Abolishes interaction with sumoylated RANGAP1
Mutagenesis26341I → K: Abolishes interaction with sumoylated RANGAP1
Mutagenesis26351V → K: Abolishes interaction with sumoylated RANGAP1
Mutagenesis26401P → A: No effect on SUMO E3 ligase activity
Mutagenesis26451K → A: No effect on SUMO E3 ligase activity
Mutagenesis26511L → A: Abolishes binding to UBE2I and SUMO E3 ligase activity
Mutagenesis26521K → A: No effect on SUMO E3 ligase activity
Mutagenesis26531L → A: Abolishes binding to UBE2I and SUMO E3 ligase activity
Mutagenesis26541P → A: Impairs SUMO E3 ligase activity
Mutagenesis26551P → A: No effect on SUMO E3 ligase activity
Mutagenesis26561T → A: Impairs SUMO E3 ligase activity
Mutagenesis26571F → A: Abolishes binding to UBE2I and SUMO E3 ligase activity
Mutagenesis26581F → A: Abolishes binding to UBE2I and SUMO E3 ligase activity
Mutagenesis26591C → S or A: Impairs SUMO E3 ligase activity
Mutagenesis26761D → A: Impairs SUMO E3 ligase activity
Mutagenesis26771F → A: Impairs SUMO E3 ligase activity
Mutagenesis26891Y → A: Impairs SUMO E3 ligase activity
Sequence conflict7771H → R in AAC41758. Ref.1
Sequence conflict22071S → A in AAA85838. Ref.5</